In addition, these findings reveal corticosteroid use as an important exclusion criterion for experimental treatment of OA and RA with FR-β-based therapeutic approaches, as targeting of FR-β+ anti-inflammatory (M2) macrophages could be detrimental. Here, FOLR2 is linked to rheumatoid arthritis.